{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:35:20Z","timestamp":1787315720027,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To describe a patient with metastatic clear cell renal cell carcinoma in remission on maintenance nivolumab therapy who developed late-onset ocular toxicity manifesting as creamy chorioretinal lesions with exudative retinal detachment concerning for choroidal metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>Case report. Main outcome measures include ophthalmoscopic examination, fundus photography, fundus autofluorescence, fluorescein angiography, indocyanine green angiography, spectral domain optical coherence tomography, and B-scan ultrasonography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A 49-year-old woman with a medical history of metastatic clear cell renal cell carcinoma in remission for two years after immunotherapy with four cycles of ipilimumab and nivolumab followed by maintenance nivolumab infusions developed lesions concerning for choroidal metastases in her right eye. Optical coherence tomography of the lesions revealed a bacillary layer detachment containing possible fibrinous exudate organized into layers and underlying choroidal thickening with chorioretinal folds. Later, choroidal thickening and chorioretinal folds also occurred in the left eye. Given that pan imaging detected no metastasis and the posterior segment abnormalities resolved after cessation of nivolumab and treatment with systemic corticosteroids, the patient was diagnosed with nivolumab-induced Vogt\u2013Koyanagi\u2013Harada-like uveitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This case expands on the clinical spectrum of nivolumab-induced Vogt\u2013Koyanagi\u2013Harada-like uveitis, a condition that can also present with bacillary layer detachment mimicking an early choroidal metastasis, manifest asymmetrically in each eye, and develop after long-standing treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/icb.0000000000001165","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T09:00:53Z","timestamp":1621846853000},"page":"233-238","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["NIVOLUMAB-INDUCED HARADA-LIKE UVEITIS WITH BACILLARY DETACHMENT MIMICKING CHOROIDAL METASTASIS"],"prefix":"10.1097","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2462-0485","authenticated-orcid":false,"given":"Caleb C.","family":"Ng","sequence":"first","affiliation":[{"name":"West Coast Retina Medical Group, San Francisco, California; and"},{"name":"Department of Ophthalmology, California Pacific Medical Center, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C.","family":"Ng","sequence":"additional","affiliation":[{"name":"West Coast Retina Medical Group, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Johnson","sequence":"additional","affiliation":[{"name":"West Coast Retina Medical Group, San Francisco, California; and"},{"name":"Department of Ophthalmology, California Pacific Medical Center, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Richard","family":"McDonald","sequence":"additional","affiliation":[{"name":"West Coast Retina Medical Group, San Francisco, California; and"},{"name":"Department of Ophthalmology, California Pacific Medical Center, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Agarwal","sequence":"additional","affiliation":[{"name":"West Coast Retina Medical Group, San Francisco, California; and"},{"name":"Department of Ophthalmology, California Pacific Medical Center, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250507","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/IAE.0000000000002181","article-title":"Checkpoint inhibitor immune therapy: systemic indications and ophthalmic side effects","volume":"38","author":"Dalvin","year":"2018","journal-title":"Retina"},{"key":"R2-20250507","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/ICB.0000000000000675","article-title":"Immune retinopathy associated with nivolumab administration for metastatic non-small cell lung cancer","volume":"14","author":"Reddy","year":"2020","journal-title":"Retin Cases Brief Rep"},{"key":"R3-20250507","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ccr3.911","article-title":"Vogt\u2010Koyanagi\u2010Harada disease\u2010like posterior uveitis in the course of nivolumab (anti\u2010PD\u20101 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma","volume":"5","author":"Matsuo","year":"2017","journal-title":"Clin Case Rep"},{"key":"R4-20250507","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jamaophthalmol.2017.4872","article-title":"Combination ipilimumab and nivolumab for metastatic melanoma associated with ciliochoroidal effusion and exudative retinal detachment","volume":"135","author":"Tsui","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R5-20250507","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/1346-8138.14273","article-title":"HLA\u2010DRB 1* 04: 05 in two cases of Vogt\u2013Koyanagi\u2013Harada disease\u2010like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib\/trametinib therapy","volume":"45","author":"Fujimura","year":"2018","journal-title":"J Dermatol"},{"key":"R6-20250507","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000496682","article-title":"Vogt-Koyanagi-Harada disease-like uveitis during Nivolumab (anti-PD-1 antibody) treatment for metastatic cutaneous malignant melanoma","volume":"10","author":"Obata","year":"2019","journal-title":"Case Rep Ophthalmol"},{"key":"R7-20250507","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00262-018-2260-7","article-title":"Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma","volume":"68","author":"Wang","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"R8-20250507","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1080\/09273948.2019.1582785","article-title":"Intraocular concentrations of cytokines and chemokines in a unique case of nivolumab-induced uveitis","volume":"28","author":"Yoshida","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R9-20250507","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1080\/09273948.2019.1583347","article-title":"Ocular adverse events following use of immune checkpoint inhibitors for metastatic malignancies","volume":"28","author":"Noble","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R10-20250507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-020-01519-5","article-title":"Vogt\u2013Koyanagi\u2013Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report","volume":"20","author":"Kikuchi","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"R11-20250507","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.oret.2019.12.003","article-title":"The bacillary detachment in posterior segment ocular diseases","volume":"4","author":"Cicinelli","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"R12-20250507","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/IAE.0000000000000131","article-title":"Enhanced depth imaging optical coherence tomography of choroidal metastasis in 14 eyes","volume":"34","author":"Al-Dahmash","year":"2014","journal-title":"Retina"},{"key":"R13-20250507","article-title":"Vogt-Koyanagi-Harada-like uveitis followed by melanoma-associated retinopathy with focal chorioretinal atrophy and choroidal neovascularization in a patient with metastatic cutaneous melanoma","author":"Ng","year":"2020","journal-title":"Retin Cases Brief Rep"},{"key":"R14-20250507","first-page":"1183","article-title":"Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report","volume":"10","author":"Richardson","year":"2017","journal-title":"Int J Ophthalmol"}],"container-title":["RETINAL Cases &amp; Brief Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICB.0000000000001165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T17:14:32Z","timestamp":1746638072000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICB.0000000000001165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/icb.0000000000001165","relation":{},"ISSN":["1935-1089"],"issn-type":[{"value":"1935-1089","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}